Alflutinib Mesylate

Alflutinib Mesylate

AOB16487

CAS 2130958-55-1

More details

1000 Items

$0.00

Overview

Novel third-generation irreversible EGFR TKI for the treatment of non-small cell lung cancer (NSCLC) with EGFR-sensitizing and T790M resistance mutations